Samuel Hintermann

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Venues

Journal of medicinal chemistry

RSC chemical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Vulpetti, Jean-Michel Rondeau, Marie-Hélène Bellance, Jutta Blank, Ralf Boesch, Andreas Boettcher, Frédéric Bornancin, Sylvia Buhr, Lauren E Connor, Christoph E Dumelin, Oliver Esser, Michael Hediger, Samuel Hintermann, Ulrich Hommel, Elke Koch, Guillaume Lapointe, Lukas Leder, Sylvie Lehmann, Philipp Lehr, Peter Meier, Lionel Muller, Daniela Ostermeier, Paul Ramage, Sihame Schiebel-Haddad, Alexander Baxter Smith, Aleksandar Stojanovic, Juraj Velcicky, Rina Yamamoto, Konstanze Hurth
Ligandability Assessment of IL-1β by Integrated Hit Identification Approaches. Journal of medicinal chemistry (2024)
Anna Vulpetti, Jean-Michel Rondeau, Marie-Hélène Bellance, Jutta Blank, Ralf Boesch, Andreas Boettcher, Frédéric Bornancin, Sylvia Buhr, Lauren E Connor, Christoph E Dumelin, Oliver Esser, Michael Hediger, Samuel Hintermann, Ulrich Hommel, Elke Koch, Guillaume Lapointe, Lukas Leder, Sylvie Lehmann, Philipp Lehr, Peter Meier, Lionel Muller, Daniela Ostermeier, Paul Ramage, Sihame Schiebel-Haddad, Alexander Baxter Smith, Aleksandar Stojanovic, Juraj Velcicky, Rina Yamamoto, Konstanze Hurth
Ligandability Assessment of IL-1β by Integrated Hit Identification Approaches. Journal of medicinal chemistry 67 (10) (2024)
Anna Vulpetti, Jean-Michel Rondeau, Marie-Hélène Bellance, Jutta Blank, Ralf Boesch, Andreas Boettcher, Frédéric Bornancin, Sylvia Buhr, Lauren E Connor, Christoph E Dumelin, Oliver Esser, Michael Hediger, Samuel Hintermann, Ulrich Hommel, Elke Koch, Guillaume Lapointe, Lukas Leder, Sylvie Lehmann, Philipp Lehr, Peter Meier, Lionel Muller, Daniela Ostermeier, Paul Ramage, Sihame Schiebel-Haddad, Alexander Baxter Smith, Aleksandar Stojanovic, Juraj Velcicky, Rina Yamamoto, Konstanze Hurth
Ligandability Assessment of IL-1β by Integrated Hit Identification Approaches. Journal of medicinal chemistry 67 (10) (2024)
Anselm F L Schneider, Joerg Kallen, Johannes Ottl, Patrick C Reid, Sebastien Ripoche, Stephan Ruetz, Therese-Marie Stachyra, Samuel Hintermann, Christoph E Dumelin, Christian P R Hackenberger, Andreas L Marzinzik
Discovery, X-ray structure and CPP-conjugation enabled uptake of p53/MDM2 macrocyclic peptide inhibitors. RSC chemical biology 2 (6) (2021)
Ansgar Schuffenhauer, Nadine Schneider, Samuel Hintermann, Douglas S Auld, Jutta Blank, Simona Cotesta, Caroline Engeloch, Nikolas Fechner, Christoph Gaul, Jerome Giovannoni, Johanna M Jansen, John Joslin, Philipp Krastel, Eugen Lounkine, John Manchester, Lauren G Monovich, Anna Paola Pelliccioli, Manuel Schwarze, Michael D Shultz, Nikolaus Stiefl, Daniel K Baeschlin
Evolution of Novartis' Small Molecule Screening Deck Design. Journal of medicinal chemistry 63 (23) (2020)
Klemens Hoegenauer, Joerg Kallen, Eloísa Jiménez-Núñez, Ross Strang, Peter Ertl, Nigel G Cooke, Samuel Hintermann, Markus Voegtle, Claudia Betschart, Daniel J J McKay, Juergen Wagner, Johannes Ottl, Christian Beerli, Andreas Billich, Janet Dawson, Klemens Kaupmann, Markus Streiff, Nathalie Gobeau, Stephanie Harlfinger, Rowan Stringer, Christine Guntermann
Structure-Based and Property-Driven Optimization of N-Aryl Imidazoles toward Potent and Selective Oral RORγt Inhibitors. Journal of medicinal chemistry 62 (23) (2019)
David A Carcache, Anna Vulpetti, Joerg Kallen, Henri Mattes, David Orain, Rowan Stringer, Eric Vangrevelinghe, Romain M Wolf, Klemens Kaupmann, Johannes Ottl, Janet Dawson, Nigel G Cooke, Klemens Hoegenauer, Andreas Billich, Juergen Wagner, Christine Guntermann, Samuel Hintermann
Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model. Journal of medicinal chemistry 61 (15) (2018)

Samuel Hintermann.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Samuel Hintermann